Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesConexeu Sciences Inc. Common Stock

Conexeu Sciences Inc. Common Stock

Healthcare Biotechnology
PortfolioPortfolio WatchlistWatchlist
Company price
2.26 USD 0.00(0%)
Last update at 2026-11-09T18:11:00Z
VOLUME
117690
Market Cap
125.52M

Momentum Score

…

Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair. The company provides patented collagen-based scaffold products, including a collagen extracellular matrix (ECM) scaffold platform for use in medical aesthetics, wound care, tissue repair, facial rejuvenation, and large-volume body contouring such as face, breast, and butt volume restoration. Its CXU collagen gel is an investigational product targeting therapeutic and aesthetic indications, supporting tissue regeneration and aiming to minimize inflammation or fibrosis. The company's solutions are supported by preclinical and peer-reviewed data and are positioned as alternatives to conventional fillers or implants, with products currently investigational and pending regulatory clearance for certain applications. The company serves clients in the beauty, aesthetics, regenerative medicine, and medical sectors, including clinicians and professionals involved in facial rejuvenation, body contouring, wound care, and tissue repair. The company was founded in 2022 and is based in Reno, Nevada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
2.19
Low
2.31
High
52 Week Price Range
4.19
Low
18.79
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public information on Conexeu Sciences Inc. (NASDAQ: CNXU) is limited, and widely available disclosures do not clearly define its core operations. Any potential long-term growth would depend on successful development and commercialization of its purported products or services, strategic partnerships and access to capital; investors may find upside if those milestones are achieved, but the company’s prospects appear speculative.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
2.26
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
0.00M
Debt / Equity
-
ROE
-
Net Debt
-
ROCE
-53.84%
Diluted EPS TTM
-0.31

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-10-31 2024-10-31
Type yearly yearly
Date 2025-10-31 2024-10-31
Income before tax -3.92M -0.47M
Net income -3.92M -0.47M
Selling general administrative 3.45M 0.36M
Reconciled depreciation 0.02M 0.00M
Operating income -3.96M -0.64M
Interest expense 0.00M 0.02M
Tax provision 0.00M 0.00M
Interest income 0.00M 0.00M
Net interest income -0.01M -0.02M
Total revenue 0.00M 0.00M
Total operating expenses 3.96M 0.64M
Total other income expense net 0.04M 0.19M
Net income from continuing ops -3.92M -0.47M
Breakdown 2025-10-31 2024-10-31
Type yearly yearly
Date 2025-10-31 2024-10-31
Total assets 7.69M 0.53M
Intangible assets 0.18M 0.19M
Total liab 0.34M 0.44M
Total stockholder equity 7.35M 0.09M
Capital stock 0.02M 0.01M
Retained earnings -4.52M -0.60M
Cash 4.81M 0.31M
Total current liabilities 0.34M 0.34M
Total current assets 7.46M 0.35M
Long term debt - 0.10M
Accounts payable 0.26M 0.32M
Non current assets total 0.23M 0.19M
Breakdown 2025-10-31 2024-10-31
Type yearly yearly
Date 2025-10-31 2024-10-31
Net borrowings -0.09M 0.00M
Total cash from financing activities 6.28M 0.53M
Net income -3.92M -0.47M
Change in cash 4.52M 0.31M
Begin period cash flow 0.31M 0.00M
End period cash flow 4.83M 0.31M
Total cash from operating activities -1.67M -0.23M
Issuance of capital stock 6.42M 0.53M
Depreciation 0.02M 0.00M
Capital expenditures 0.02M 0.00M
Change in working capital 0.10M 0.42M
Stock based compensation 1.34M 0.01M
Other non cash items 0.79M -0.22M
Free cash flow -1.69M -0.23M

Peer Comparison*

Sector: Healthcare Industry: Biotechnology

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
CNXU
Conexeu Sciences Inc. Common Stock		 -
-%		 2.26 - - - 19.48
NVO
Novo Nordisk A/S		 1.03
2.56%		 41.34 41.58 31.15 2.13 32.99
VRTX
Vertex Pharmaceuticals Inc		 1.49
0.27%		 548.58 30.22 24.27 10.36 6.50
REGN
Regeneron Pharmaceuticals Inc		 18.16
2.01%		 922.51 29.07 20.12 7.57 3.82
ARGNF
argenx SE		 -
-%		 900.30 45.77 31.25 13.84 7.12

Profile*

Conexeu Sciences Inc. Common Stock

Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair. The company provides patented collagen-based scaffold products, including a collagen extracellular matrix (ECM) scaffold platform for use in medical aesthetics, wound care, tissue repair, facial rejuvenation, and large-volume body contouring such as face, breast, and butt volume restoration. Its CXU collagen gel is an investigational product targeting therapeutic and aesthetic indications, supporting tissue regeneration and aiming to minimize inflammation or fibrosis. The company's solutions are supported by preclinical and peer-reviewed data and are positioned as alternatives to conventional fillers or implants, with products currently investigational and pending regulatory clearance for certain applications. The company serves clients in the beauty, aesthetics, regenerative medicine, and medical sectors, including clinicians and professionals involved in facial rejuvenation, body contouring, wound care, and tissue repair. The company was founded in 2022 and is based in Reno, Nevada.

50 West Liberty Street, Reno, NV, United States, 89501

(604) 315-4722

https://www.conexeu.com

Name Title Year Born
Mr. Miles D. Harrison President, CEO & Director 1965
Mr. David R. Bogart Founder, Chief Commercial Officer & Director 1970
Dr. Claudia Chavez-Munoz M.D., Ph.D. Founder & Chief Scientific Officer 1980
Mr. Stephen D. Inouye CFO, Corporate Secretary & Treasurer 1961
Dr. Brian K. Pilcher Ph.D. Chief Medical Officer 1969
Ms. Sonia Thomas M.B.A. Head of Strategy & Transformation NA
Mr. Jean-Romain Falconne Head of Business Development & Licensing NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

GFR
CAD 10.93
+37.83%
MOON
CAD 4.86
+10.20%
HG
CAD 4.43
+9.93%
EPRX
CAD 10.57
+8.86%
NUAG
CAD 8.66
+8.79%
CSU
CAD 3257.60
-7.63%
DIV
CAD 3.85
-5.53%
TOI
CAD 99.00
-5.52%
BSX
CAD 0.82
-4.65%
LMN
CAD 26.79
-4.63%

Equity Sectors*

  • Basic Materials

    +3.88%

  • Communication Services

    -1.14%

  • Consumer Cyclical

    +0.75%

  • Consumer Defensive

    -0.36%

  • Energy

    +2.16%

  • Financial Services

    +1.33%

  • Healthcare

    +1.50%

  • Industrials

    +2.97%

  • Real Estate

    +0.41%

  • Technology

    +1.27%

  • Utilities

    +1.09%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…